Medisieve Ltd

MediSieve is a multi-award-winning medical device company developing Magnetic Blood Filtration (MBF), an extracorporeal technology similar to dialysis, in which Targeted Magnetic Particles (TB-MPs) are infused into the extracorporeal loop, binding specifically to disease-relevant targets in the patient's blood. The blood then flows through a Magnetic Filt...

no public description

MediSieve is a medical device company developing "magnetic blood filtration": a revolutionary treatment for blood-borne diseases which removes pathogens directly from the bloodstream. Our technology is like dialysis, circulating a patient's blood through an external loop to remove disease causing targets. While dialysis relies on non-specific size based f...

MediSieve is developing "SepSieve" a novel method of treating sepsis by removing specific diseases-causing components directly from patient's bloodstreams. The process is similar to dialysis - a patient's blood is circulated through an extra-corporeal loop, passing through MediSieve's system which specifically targets and extracts unwanted substances. The...

With 200 million cases a year, and the death of a child every minute, malaria remains one of the world’s biggest problems. One issue is that patients get to hospital too late for drug treatments to be effective, with mortality rates of up to 20% due to high parasite burdens. The drugs are toxic, and can cause serious side-effects. The chances of survival ...

Help in establishing the IP strategy for a novel medical device which could lead to new, personalised treatments and diagnoses. The device is a novel use of an old, established technology, and there is therefore a significant amount of prior art which could limit patenting options. The innovation voucher will help us consult with experts to establish how ...